HIGHTOUCHRX Trademark

Trademark Overview


On Thursday, June 24, 2021, a trademark application was filed for HIGHTOUCHRX with the United States Patent and Trademark Office. The USPTO has given the HIGHTOUCHRX trademark a serial number of 90793338. The federal status of this trademark filing is REGISTERED as of Tuesday, July 12, 2022. This trademark is owned by Prime Therapeutics LLC. The HIGHTOUCHRX trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:

Pharmacy benefit management services

Pharmaceutical cost management services; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of data pertaining to pharmaceuticals for business purposes; providing business management information in connection with consulting and advisory services to the healthcare industry in the field of prescription drug savings; business management consulting relating to prescription drug costs using analytic and predictive models applied to medical and pharmacy data; medical cost management consulting in the field of drug therapies
hightouchrx

General Information


Serial Number90793338
Word MarkHIGHTOUCHRX
Filing DateThursday, June 24, 2021
Status700 - REGISTERED
Status DateTuesday, July 12, 2022
Registration Number6791625
Registration DateTuesday, July 12, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkHIGH TOUCH RX; HIGH TOUCH PRESCRIPTIONS
Goods and ServicesPharmacy benefit management services
Goods and ServicesPharmaceutical cost management services; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of data pertaining to pharmaceuticals for business purposes; providing business management information in connection with consulting and advisory services to the healthcare industry in the field of prescription drug savings; business management consulting relating to prescription drug costs using analytic and predictive models applied to medical and pharmacy data; medical cost management consulting in the field of drug therapies

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 8, 2021
Primary Code035
First Use Anywhere DateSaturday, January 1, 2022
First Use In Commerce DateSaturday, January 1, 2022

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 8, 2021
Primary Code036
First Use Anywhere DateSaturday, January 1, 2022
First Use In Commerce DateSaturday, January 1, 2022

Trademark Owner History


Party NamePrime Therapeutics LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressEagan, MN 55121

Party NamePrime Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEagan, MN 55121

Trademark Events


Event DateEvent Description
Thursday, December 21, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 21, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 21, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 21, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 21, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 12, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 12, 2022REGISTERED-SUPPLEMENTAL REGISTER
Friday, June 3, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 27, 2022ASSIGNED TO LIE
Thursday, May 26, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, May 25, 2022APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, May 25, 2022USE AMENDMENT ACCEPTED
Tuesday, April 26, 2022AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, April 26, 2022USE AMENDMENT FILED
Monday, April 25, 2022TEAS AMENDMENT OF USE RECEIVED
Monday, April 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 6, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 6, 2021NON-FINAL ACTION E-MAILED
Monday, December 6, 2021NON-FINAL ACTION WRITTEN
Friday, December 3, 2021ASSIGNED TO EXAMINER
Wednesday, September 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 28, 2021NEW APPLICATION ENTERED